AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $3.61 and traded as high as $6.25. AIkido Pharma shares last traded at $5.99, with a volume of 495,403 shares.
AIkido Pharma Stock Up 12.6%
The firm has a market capitalization of $32.86 million, a price-to-earnings ratio of -1.54 and a beta of 0.93. The company’s 50 day moving average price is $4.69 and its 200 day moving average price is $3.61.
About AIkido Pharma
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Further Reading
- Five stocks we like better than AIkido Pharma
- Why Invest in High-Yield Dividend Stocks?
- Palantir’s Latest Deal Could Put a Freeze on Its Stock Price
- How to buy stock: A step-by-step guide for beginners
- 4 Automaker Stocks React to Tariffs: Winners and Losers
- How Technical Indicators Can Help You Find Oversold Stocks
- Here’s Why Call Option Traders Love Dutch Bros Stock
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
